APO Research
Talk to an analyst

APO RESEARCH · REPORT

Butorphanol

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Butorphanol Industry Growth and Trends Forecast to 2032

19 December 2025116 pages

Choose your research edition.

Industry ResearchButorphanol Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Butorphanol Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Butorphanol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Butorphanol Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Butorphanol Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Butorphanol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Butorphanol include Zoetis, Merck KGaA, Mylan, Pfizer, Troy Laboratories Nz, Selectavet, Sanochemia Pharmazeutika, Richter Pharma Ag and Novex Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Butorphanol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Butorphanol market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Butorphanol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Butorphanol.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Butorphanol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Butorphanol Market by Company

Zoetis

Merck KGaA

Mylan

Pfizer

Troy Laboratories Nz

Selectavet

Sanochemia Pharmazeutika

Richter Pharma Ag

Novex Pharma

Hikma Pharmaceuticals

Faunapharma

Dechra Pharmaceuticals

Bristol Myers Squibb

Boehringer Ingelheim Santé Animale

Ausrichter

Athanas Enterprise Private Limited

Apothecon Pharmaceuticals

Animedica

Butorphanol Segment by Type

Injection

Spray

Tablet

Butorphanol Segment by Application

Human

Veterinary

Butorphanol Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Butorphanol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Butorphanol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Butorphanol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Butorphanol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Butorphanol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Spray Table 3. Major Company of Tablet Table 4. Global Butorphanol Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Butorphanol Sales by Type (2021-2026) & (K Units) Table 6. Global Butorphanol Sales Market Share in Volume by Type (2021-2026) Table 7. Global Butorphanol Sales by Type (2021-2026) & (US$ Million) Table 8. Global Butorphanol Sales Market Share in Value by Type (2021-2026) Table 9. Global Butorphanol Price by Type (2021-2026) & (US$/Unit) Table 10. Global Butorphanol Sales by Type (2027-2032) & (K Units) Table 11. Global Butorphanol Sales Market Share in Volume by Type (2027-2032) Table 12. Global Butorphanol Sales by Type (2027-2032) & (US$ Million) Table 13. Global Butorphanol Sales Market Share in Value by Type (2027-2032) Table 14. Global Butorphanol Price by Type (2027-2032) & (US$/Unit) Table 15. North America Butorphanol Sales by Type (2021-2026) & (K Units) Table 16. North America Butorphanol Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Butorphanol Sales by Type (2021-2026) & (K Units) Table 18. Europe Butorphanol Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Butorphanol Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Butorphanol Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Butorphanol Sales by Type (2021-2026) & (K Units) Table 22. Latin America Butorphanol Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Butorphanol Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Butorphanol Sales by Type (2021-2026) & (US$ Million) Table 25. Butorphanol Industry Trends Table 26. Butorphanol Industry Drivers Table 27. Butorphanol Industry Opportunities and Challenges Table 28. Butorphanol Industry Restraints Table 29. Global Butorphanol Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Butorphanol Revenue Market Share by Company (2021-2026) Table 31. Global Butorphanol Sales by Company (2021-2026) & (K Units) Table 32. Global Butorphanol Sales Share by Company (2021-2026) Table 33. Global Butorphanol Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Butorphanol Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Butorphanol Major Company Production Sites and Headquarters Table 36. Global Butorphanol Company, Product Type & Application Table 37. Global Butorphanol Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Butorphanol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Butorphanol Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Butorphanol Sales by Region (2021-2026) & (K Units) Table 42. Global Butorphanol Sales Market Share in Volume by Region (2021-2026) Table 43. Global Butorphanol Sales by Region (2021-2026) & (US$ Million) Table 44. Global Butorphanol Sales Market Share in Value by Region (2021-2026) Table 45. Global Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Butorphanol Sales by Region (2027-2032) & (K Units) Table 47. Global Butorphanol Sales Market Share in Volume by Region (2027-2032) Table 48. Global Butorphanol Sales by Region (2027-2032) & (US$ Million) Table 49. Global Butorphanol Sales Market Share in Value by Region (2027-2032) Table 50. Global Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Butorphanol Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Butorphanol Sales by Application (2021-2026) & (K Units) Table 53. Global Butorphanol Sales Market Share in Volume by Application (2021-2026) Table 54. Global Butorphanol Sales by Application (2021-2026) & (US$ Million) Table 55. Global Butorphanol Sales Market Share in Value by Application (2021-2026) Table 56. Global Butorphanol Price by Application (2021-2026) & (US$/Unit) Table 57. Global Butorphanol Sales by Application (2027-2032) & (K Units) Table 58. Global Butorphanol Sales Market Share in Volume by Application (2027-2032) Table 59. Global Butorphanol Sales by Application (2027-2032) & (US$ Million) Table 60. Global Butorphanol Sales Market Share in Value by Application (2027-2032) Table 61. Global Butorphanol Price by Application (2027-2032) & (US$/Unit) Table 62. North America Butorphanol Sales by Application (2021-2026) & (K Units) Table 63. North America Butorphanol Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Butorphanol Sales by Application (2021-2026) & (K Units) Table 65. Europe Butorphanol Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Butorphanol Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Butorphanol Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Butorphanol Sales by Application (2021-2026) & (K Units) Table 69. Latin America Butorphanol Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Butorphanol Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Butorphanol Sales by Application (2021-2026) & (US$ Million) Table 72. Zoetis Company Information Table 73. Zoetis Business Overview Table 74. Zoetis Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Zoetis Butorphanol Product Portfolio Table 76. Zoetis Recent Development Table 77. Merck KGaA Company Information Table 78. Merck KGaA Business Overview Table 79. Merck KGaA Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck KGaA Butorphanol Product Portfolio Table 81. Merck KGaA Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mylan Butorphanol Product Portfolio Table 86. Mylan Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Butorphanol Product Portfolio Table 91. Pfizer Recent Development Table 92. Troy Laboratories Nz Company Information Table 93. Troy Laboratories Nz Business Overview Table 94. Troy Laboratories Nz Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Troy Laboratories Nz Butorphanol Product Portfolio Table 96. Troy Laboratories Nz Recent Development Table 97. Selectavet Company Information Table 98. Selectavet Business Overview Table 99. Selectavet Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Selectavet Butorphanol Product Portfolio Table 101. Selectavet Recent Development Table 102. Sanochemia Pharmazeutika Company Information Table 103. Sanochemia Pharmazeutika Business Overview Table 104. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sanochemia Pharmazeutika Butorphanol Product Portfolio Table 106. Sanochemia Pharmazeutika Recent Development Table 107. Richter Pharma Ag Company Information Table 108. Richter Pharma Ag Business Overview Table 109. Richter Pharma Ag Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Richter Pharma Ag Butorphanol Product Portfolio Table 111. Richter Pharma Ag Recent Development Table 112. Novex Pharma Company Information Table 113. Novex Pharma Business Overview Table 114. Novex Pharma Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Novex Pharma Butorphanol Product Portfolio Table 116. Novex Pharma Recent Development Table 117. Hikma Pharmaceuticals Company Information Table 118. Hikma Pharmaceuticals Business Overview Table 119. Hikma Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Hikma Pharmaceuticals Butorphanol Product Portfolio Table 121. Hikma Pharmaceuticals Recent Development Table 122. Faunapharma Company Information Table 123. Faunapharma Business Overview Table 124. Faunapharma Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Faunapharma Butorphanol Product Portfolio Table 126. Faunapharma Recent Development Table 127. Dechra Pharmaceuticals Company Information Table 128. Dechra Pharmaceuticals Business Overview Table 129. Dechra Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Dechra Pharmaceuticals Butorphanol Product Portfolio Table 131. Dechra Pharmaceuticals Recent Development Table 132. Bristol Myers Squibb Company Information Table 133. Bristol Myers Squibb Business Overview Table 134. Bristol Myers Squibb Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Bristol Myers Squibb Butorphanol Product Portfolio Table 136. Bristol Myers Squibb Recent Development Table 137. Boehringer Ingelheim Santé Animale Company Information Table 138. Boehringer Ingelheim Santé Animale Business Overview Table 139. Boehringer Ingelheim Santé Animale Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio Table 141. Boehringer Ingelheim Santé Animale Recent Development Table 142. Ausrichter Company Information Table 143. Ausrichter Business Overview Table 144. Ausrichter Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Ausrichter Butorphanol Product Portfolio Table 146. Ausrichter Recent Development Table 147. Athanas Enterprise Private Limited Company Information Table 148. Athanas Enterprise Private Limited Business Overview Table 149. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Athanas Enterprise Private Limited Butorphanol Product Portfolio Table 151. Athanas Enterprise Private Limited Recent Development Table 152. Apothecon Pharmaceuticals Company Information Table 153. Apothecon Pharmaceuticals Business Overview Table 154. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Apothecon Pharmaceuticals Butorphanol Product Portfolio Table 156. Apothecon Pharmaceuticals Recent Development Table 157. Animedica Company Information Table 158. Animedica Business Overview Table 159. Animedica Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Animedica Butorphanol Product Portfolio Table 161. Animedica Recent Development Table 162. North America Butorphanol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. North America Butorphanol Sales by Country (2021-2026) & (K Units) Table 164. North America Butorphanol Sales Market Share by Country (2021-2026) Table 165. North America Butorphanol Sales Forecast by Country (2027-2032) & (K Units) Table 166. North America Butorphanol Sales Market Share Forecast by Country (2027-2032) Table 167. North America Butorphanol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. North America Butorphanol Market Size by Country (2021-2026) & (US$ Million) Table 169. North America Butorphanol Market Share by Country (2021-2026) Table 170. North America Butorphanol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. North America Butorphanol Market Share Forecast by Country (2027-2032) Table 172. Europe Butorphanol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Europe Butorphanol Sales by Country (2021-2026) & (K Units) Table 174. Europe Butorphanol Sales Market Share by Country (2021-2026) Table 175. Europe Butorphanol Sales Forecast by Country (2027-2032) & (K Units) Table 176. Europe Butorphanol Sales Market Share Forecast by Country (2027-2032) Table 177. Europe Butorphanol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Europe Butorphanol Market Size by Country (2021-2026) & (US$ Million) Table 179. Europe Butorphanol Market Share by Country (2021-2026) Table 180. Europe Butorphanol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Europe Butorphanol Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Butorphanol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Butorphanol Sales by Country (2021-2026) & (K Units) Table 184. Asia-Pacific Butorphanol Sales Market Share by Country (2021-2026) Table 185. Asia-Pacific Butorphanol Sales Forecast by Country (2027-2032) & (K Units) Table 186. Asia-Pacific Butorphanol Sales Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific Butorphanol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific Butorphanol Market Size by Country (2021-2026) & (US$ Million) Table 189. Asia-Pacific Butorphanol Market Share by Country (2021-2026) Table 190. Asia-Pacific Butorphanol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Asia-Pacific Butorphanol Market Share Forecast by Country (2027-2032) Table 192. Latin America Butorphanol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 193. Latin America Butorphanol Sales by Country (2021-2026) & (K Units) Table 194. Latin America Butorphanol Sales Market Share by Country (2021-2026) Table 195. Latin America Butorphanol Sales Forecast by Country (2027-2032) & (K Units) Table 196. Latin America Butorphanol Sales Market Share Forecast by Country (2027-2032) Table 197. Latin America Butorphanol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Latin America Butorphanol Market Size by Country (2021-2026) & (US$ Million) Table 199. Latin America Butorphanol Market Share by Country (2021-2026) Table 200. Latin America Butorphanol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Latin America Butorphanol Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Butorphanol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Butorphanol Sales by Country (2021-2026) & (K Units) Table 204. Middle East and Africa Butorphanol Sales Market Share by Country (2021-2026) Table 205. Middle East and Africa Butorphanol Sales Forecast by Country (2027-2032) & (K Units) Table 206. Middle East and Africa Butorphanol Sales Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa Butorphanol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa Butorphanol Market Size by Country (2021-2026) & (US$ Million) Table 209. Middle East and Africa Butorphanol Market Share by Country (2021-2026) Table 210. Middle East and Africa Butorphanol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Middle East and Africa Butorphanol Market Share Forecast by Country (2027-2032) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Butorphanol Distributors List Table 215. Butorphanol Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Butorphanol Image Figure 2. Global Butorphanol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Butorphanol Market Size (2021-2032) & (US$ Million) Figure 4. Global Butorphanol Sales (2021-2032) & (K Units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Spray Image Figure 8. Global Spray Sales YoY Growth (2021-2032) & (K Units) Figure 9. Tablet Image Figure 10. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Butorphanol Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Butorphanol Market Share by Type 2025 VS 2032 Figure 13. North America Butorphanol Sales Market Share in Volume by Type in 2025 Figure 14. North America Butorphanol Sales Market Share in Value by Type in 2025 Figure 15. Europe Butorphanol Sales Market Share in Volume by Type in 2025 Figure 16. Europe Butorphanol Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Butorphanol Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Butorphanol Sales Market Share in Value by Type in 2025 Figure 19. Latin America Butorphanol Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Butorphanol Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Butorphanol Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Butorphanol Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Butorphanol Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Human Image Figure 26. Global Human Sales YoY Growth (2021-2032) & (K Units) Figure 27. Veterinary Image Figure 28. Global Veterinary Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Butorphanol Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Butorphanol Market Share by Application 2025 VS 2032 Figure 31. North America Butorphanol Sales Market Share in Volume by Application in 2025 Figure 32. North America Butorphanol Sales Market Share in Value by Application in 2025 Figure 33. Europe Butorphanol Sales Market Share in Volume by Application in 2025 Figure 34. Europe Butorphanol Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Butorphanol Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Butorphanol Sales Market Share in Value by Application in 2025 Figure 37. Latin America Butorphanol Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Butorphanol Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Butorphanol Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Butorphanol Sales Market Share in Value by Application in 2025 Figure 41. North America Butorphanol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Butorphanol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Butorphanol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Butorphanol Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Butorphanol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Butorphanol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Butorphanol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Butorphanol Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Butorphanol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Butorphanol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Butorphanol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Butorphanol Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Butorphanol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Butorphanol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Butorphanol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Butorphanol Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Butorphanol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Butorphanol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Butorphanol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Butorphanol Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Butorphanol Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Butorphanol Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Spray
  • Tablet
Applications
  • Human
  • Veterinary
Companies covered
  • Zoetis
  • Merck KGaA
  • Mylan
  • Pfizer
  • Troy Laboratories Nz
  • Selectavet
  • Sanochemia Pharmazeutika
  • Richter Pharma Ag
  • Novex Pharma
  • Hikma Pharmaceuticals
  • Faunapharma
  • Dechra Pharmaceuticals
  • Bristol Myers Squibb
  • Boehringer Ingelheim Santé Animale
  • Ausrichter
  • Athanas Enterprise Private Limited
  • Apothecon Pharmaceuticals
  • Animedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Butorphanol Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Butorphanol Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Butorphanol Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Spray
  8. 1.3.3 Tablet
  9. 1.4 Global Butorphanol Market Size by Type
  10. 1.4.1 Global Butorphanol Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Butorphanol Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Butorphanol Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Butorphanol Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Butorphanol Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Butorphanol Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Butorphanol Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Butorphanol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Butorphanol Industry Trends
  2. 2.2 Butorphanol Industry Drivers
  3. 2.3 Butorphanol Industry Opportunities and Challenges
  4. 2.4 Butorphanol Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Butorphanol Revenue (2021-2026)
  2. 3.2 Global Top Players by Butorphanol Sales (2021-2026)
  3. 3.3 Global Top Players by Butorphanol Price (2021-2026)
  4. 3.4 Global Butorphanol Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Butorphanol Major Company Production Sites & Headquarters
  6. 3.6 Global Butorphanol Company, Product Type & Application
  7. 3.7 Global Butorphanol Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Butorphanol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Butorphanol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Butorphanol Tier 1, Tier 2, and Tier 3
4 Butorphanol Regional Status and Outlook
  1. 4.1 Global Butorphanol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Butorphanol Historic Market Size by Region
  3. 4.2.1 Global Butorphanol Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Butorphanol Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Butorphanol Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Butorphanol Forecasted Market Size by Region
  7. 4.3.1 Global Butorphanol Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Butorphanol Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Butorphanol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Butorphanol by Application
  1. 5.1 Butorphanol Market by Application
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Butorphanol Market Size by Application
  5. 5.2.1 Global Butorphanol Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Butorphanol Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Butorphanol Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Butorphanol Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Butorphanol Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Butorphanol Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Butorphanol Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Butorphanol Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Butorphanol Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Merck KGaA
  8. 6.2.1 Merck KGaA Company Information
  9. 6.2.2 Merck KGaA Business Overview
  10. 6.2.3 Merck KGaA Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck KGaA Butorphanol Product Portfolio
  12. 6.2.5 Merck KGaA Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Butorphanol Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Butorphanol Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Troy Laboratories Nz
  26. 6.5.1 Troy Laboratories Nz Company Information
  27. 6.5.2 Troy Laboratories Nz Business Overview
  28. 6.5.3 Troy Laboratories Nz Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Troy Laboratories Nz Butorphanol Product Portfolio
  30. 6.5.5 Troy Laboratories Nz Recent Developments
  31. 6.6 Selectavet
  32. 6.6.1 Selectavet Company Information
  33. 6.6.2 Selectavet Business Overview
  34. 6.6.3 Selectavet Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Selectavet Butorphanol Product Portfolio
  36. 6.6.5 Selectavet Recent Developments
  37. 6.7 Sanochemia Pharmazeutika
  38. 6.7.1 Sanochemia Pharmazeutika Company Information
  39. 6.7.2 Sanochemia Pharmazeutika Business Overview
  40. 6.7.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanochemia Pharmazeutika Butorphanol Product Portfolio
  42. 6.7.5 Sanochemia Pharmazeutika Recent Developments
  43. 6.8 Richter Pharma Ag
  44. 6.8.1 Richter Pharma Ag Company Information
  45. 6.8.2 Richter Pharma Ag Business Overview
  46. 6.8.3 Richter Pharma Ag Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Richter Pharma Ag Butorphanol Product Portfolio
  48. 6.8.5 Richter Pharma Ag Recent Developments
  49. 6.9 Novex Pharma
  50. 6.9.1 Novex Pharma Company Information
  51. 6.9.2 Novex Pharma Business Overview
  52. 6.9.3 Novex Pharma Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novex Pharma Butorphanol Product Portfolio
  54. 6.9.5 Novex Pharma Recent Developments
  55. 6.10 Hikma Pharmaceuticals
  56. 6.10.1 Hikma Pharmaceuticals Company Information
  57. 6.10.2 Hikma Pharmaceuticals Business Overview
  58. 6.10.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hikma Pharmaceuticals Butorphanol Product Portfolio
  60. 6.10.5 Hikma Pharmaceuticals Recent Developments
  61. 6.11 Faunapharma
  62. 6.11.1 Faunapharma Company Information
  63. 6.11.2 Faunapharma Business Overview
  64. 6.11.3 Faunapharma Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Faunapharma Butorphanol Product Portfolio
  66. 6.11.5 Faunapharma Recent Developments
  67. 6.12 Dechra Pharmaceuticals
  68. 6.12.1 Dechra Pharmaceuticals Company Information
  69. 6.12.2 Dechra Pharmaceuticals Business Overview
  70. 6.12.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dechra Pharmaceuticals Butorphanol Product Portfolio
  72. 6.12.5 Dechra Pharmaceuticals Recent Developments
  73. 6.13 Bristol Myers Squibb
  74. 6.13.1 Bristol Myers Squibb Company Information
  75. 6.13.2 Bristol Myers Squibb Business Overview
  76. 6.13.3 Bristol Myers Squibb Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bristol Myers Squibb Butorphanol Product Portfolio
  78. 6.13.5 Bristol Myers Squibb Recent Developments
  79. 6.14 Boehringer Ingelheim Santé Animale
  80. 6.14.1 Boehringer Ingelheim Santé Animale Company Information
  81. 6.14.2 Boehringer Ingelheim Santé Animale Business Overview
  82. 6.14.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio
  84. 6.14.5 Boehringer Ingelheim Santé Animale Recent Developments
  85. 6.15 Ausrichter
  86. 6.15.1 Ausrichter Company Information
  87. 6.15.2 Ausrichter Business Overview
  88. 6.15.3 Ausrichter Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ausrichter Butorphanol Product Portfolio
  90. 6.15.5 Ausrichter Recent Developments
  91. 6.16 Athanas Enterprise Private Limited
  92. 6.16.1 Athanas Enterprise Private Limited Company Information
  93. 6.16.2 Athanas Enterprise Private Limited Business Overview
  94. 6.16.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Athanas Enterprise Private Limited Butorphanol Product Portfolio
  96. 6.16.5 Athanas Enterprise Private Limited Recent Developments
  97. 6.17 Apothecon Pharmaceuticals
  98. 6.17.1 Apothecon Pharmaceuticals Company Information
  99. 6.17.2 Apothecon Pharmaceuticals Business Overview
  100. 6.17.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Apothecon Pharmaceuticals Butorphanol Product Portfolio
  102. 6.17.5 Apothecon Pharmaceuticals Recent Developments
  103. 6.18 Animedica
  104. 6.18.1 Animedica Company Information
  105. 6.18.2 Animedica Business Overview
  106. 6.18.3 Animedica Butorphanol Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Animedica Butorphanol Product Portfolio
  108. 6.18.5 Animedica Recent Developments
7 North America by Country
  1. 7.1 North America Butorphanol Sales by Country
  2. 7.1.1 North America Butorphanol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Butorphanol Sales by Country (2021-2026)
  4. 7.1.3 North America Butorphanol Sales Forecast by Country (2027-2032)
  5. 7.2 North America Butorphanol Market Size by Country
  6. 7.2.1 North America Butorphanol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Butorphanol Market Size by Country (2021-2026)
  8. 7.2.3 North America Butorphanol Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Butorphanol Sales by Country
  2. 8.1.1 Europe Butorphanol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Butorphanol Sales by Country (2021-2026)
  4. 8.1.3 Europe Butorphanol Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Butorphanol Market Size by Country
  6. 8.2.1 Europe Butorphanol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Butorphanol Market Size by Country (2021-2026)
  8. 8.2.3 Europe Butorphanol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Butorphanol Sales by Country
  2. 9.1.1 Asia-Pacific Butorphanol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Butorphanol Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Butorphanol Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Butorphanol Market Size by Country
  6. 9.2.1 Asia-Pacific Butorphanol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Butorphanol Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Butorphanol Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Butorphanol Sales by Country
  2. 10.1.1 South America Butorphanol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Butorphanol Sales by Country (2021-2026)
  4. 10.1.3 South America Butorphanol Sales Forecast by Country (2027-2032)
  5. 10.2 South America Butorphanol Market Size by Country
  6. 10.2.1 South America Butorphanol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Butorphanol Market Size by Country (2021-2026)
  8. 10.2.3 South America Butorphanol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Butorphanol Sales by Country
  2. 11.1.1 Middle East and Africa Butorphanol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Butorphanol Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Butorphanol Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Butorphanol Market Size by Country
  6. 11.2.1 Middle East and Africa Butorphanol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Butorphanol Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Butorphanol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Butorphanol Value Chain Analysis
  2. 12.1.1 Butorphanol Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Butorphanol Production Mode & Process
  7. 12.2 Butorphanol Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Butorphanol Distributors
  10. 12.2.3 Butorphanol Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst